Lithium Controlled-Release and Extended-Release Tablets and Rixubis Intravenous
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Rixubis Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: coagulation factor ix
Brand name: Alphanine SD, Alprolix, BeneFIX, Idelvion, Ixinity, Mononine, Rebinyn, Rixubis, BeneFIX 250 Int'l Units, BeneFIX
Synonyms: Rixubis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Rizatriptan
- Lithium Controlled-Release and Extended-Release Tablets-Rizatriptan Benzoate
- Lithium Controlled-Release and Extended-Release Tablets-Rizatriptan Orally Disintegrating Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Rizatriptan Tablets
- Lithium Controlled-Release and Extended-Release Tablets-RMS
- Lithium Controlled-Release and Extended-Release Tablets-Robafen AC
- Rixubis Intravenous-Lithium ER
- Rixubis Intravenous-Lithium Oral Solution
- Rixubis Intravenous-Lithium Salts
- Rixubis Intravenous-Lithium Syrup and Oral Solution
- Rixubis Intravenous-Lithobid
- Rixubis Intravenous-Lithostat